Status:
RECRUITING
Resilience and Equity in Aging, Cancer, and Health (REACH)
Lead Sponsor:
Dana-Farber Cancer Institute
Conditions:
Gastric Cancer
Colon Cancer
Eligibility:
All Genders
70+ years
Phase:
NA
Brief Summary
The purpose of this multi-phase research study is to understand how consultation of cancer care with a geriatrician can best improve outcomes for older adults with gastrointestinal malignancies.
Detailed Description
This research study will be conducted in three phases: * Phase 1 - Needs assessment and implementation plan * Phase 2 - Pilot Intervention * Phase 3 - Expanded Clinical Trial * Please note Phase 2...
Eligibility Criteria
Inclusion
- Patients who are age 70+ at time of initial consult at DF/BWCC
- Diagnosed with a gastrointestinal cancer, including: cancers of the esophagus, stomach, pancreas, liver, bile duct, ampulla, colon, rectum, or anus, as well as neuroendocrine tumors.
- Continuing care at DF/BWCC beyond initial consult visit
- English and Spanish-speaking
Exclusion
- Patients less than age 70 at time of initial consultation appointment with DF/BWCC.
- Patients who are not continuing care at DF/BWCC beyond first consult visit.
- Not proficient in English or Spanish
- Patient who are not considered appropriate for enrollment due to complex medical, social, or other situation as determined by their primary oncology team.
- Participants with psychiatric illness/social situations that would limit compliance with study requirements.
Key Trial Info
Start Date :
January 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
257 Patients enrolled
Trial Details
Trial ID
NCT04674267
Start Date
January 18 2022
End Date
December 31 2026
Last Update
May 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215